Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Lexeo Therapeutics, Inc. Common Stock · LXEO

LXEONASDAQCommon stockCurrentCIK 1907108Updated Nov 19, 2026

Company: Lexeo Therapeutics, Inc. →

LXEO price & chart

Provider market data

Loading TradingView…

NASDAQ:LXEO on TradingView ↗

TradingView · Data may be delayed

About the company

Lexeo Therapeutics is a New York City-based, clinical stage company dedicated to reshaping the path of genetic disease. By advancing pioneering science, Lexeo seeks to set a new standard in the treatment of cardiovascular and neurological genetic diseases, charting the path to patient outcomes once thought out of reach. The Company is advancing a portfolio of therapeutic candidates designed to address the underlying genetic causes of disease, including LX2006 for Friedreich ataxia (FA), LX2020 for PKP2-ACM, and others in devastating diseases with high unmet need.

8-K · 2026-11-16 · 0001193125-26-462015

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-99,961,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

Operating income-109,257,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

Diluted EPS-1.86USD per share · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD143,844,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

173,865,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

254,898,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

176,068,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

192,007,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

250,356,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

125,690,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

213,205,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

268,688,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

146,942,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

139,807,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

97,076,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Property, Plant and Equipment, NetUSD1,230,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

1,180,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

1,121,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

1,115,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

1,205,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

1,101,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

1,045,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

1,044,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

1,139,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

1,028,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

1,056,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

998,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD40,996,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

157,020,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

92,834,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

35,480,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

174,981,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

71,768,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

28,913,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

195,060,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

63,000,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

35,014,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

121,466,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

77,335,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Assets, CurrentUSD127,793,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

159,458,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

217,908,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

140,062,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

177,149,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

200,862,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

105,274,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

198,089,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

188,392,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

126,121,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

124,294,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

80,048,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD5,029,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

2,438,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

6,205,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

7,169,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

2,168,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

7,819,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

5,443,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

3,029,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

6,625,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

4,603,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

——
Operating Lease, Right-of-Use AssetUSD6,963,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

8,435,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

5,783,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

7,340,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

8,781,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

6,185,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

7,708,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

9,120,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

6,578,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

8,069,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

9,442,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

10,708,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD23,013,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

34,539,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

19,837,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

37,850,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

27,059,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

18,859,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

37,575,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

30,255,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

22,019,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

30,100,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

26,272,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

24,997,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD5,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

3,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

8,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

5,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

3,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

7,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

3,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

3,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

7,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

3,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

3,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

0
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-359,215,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

-254,249,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

-426,197,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

-338,932,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

-224,760,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

-400,330,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

-312,829,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

-203,522,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

-380,134,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

-280,173,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

-181,840,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

-115,446,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD89,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

—-298,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

-13,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

—-142,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

-54,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

—188,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

-103,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

——
Stockholders' Equity Attributable to ParentUSD120,831,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

139,326,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2024-09-30

235,061,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

138,218,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2025-06-30

164,948,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2024-06-30

231,497,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

88,115,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2025-03-31

182,950,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2024-03-31

246,669,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

116,842,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

113,535,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

-112,954,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Additional Paid in Capital, Common StockUSD479,969,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

393,585,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

661,565,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

477,175,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

389,718,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

631,979,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

401,012,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

386,469,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

626,625,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

397,132,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

295,372,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

2,492,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Liabilities and EquityUSD143,844,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

173,865,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

254,898,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

176,068,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

192,007,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

250,356,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

125,690,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

213,205,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

268,688,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

146,942,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

139,807,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

97,076,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD17,271,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

26,818,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

15,692,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

31,593,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

18,877,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

14,189,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

30,823,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

21,630,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

16,808,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

22,846,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

17,239,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

14,349,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Operating Lease, Liability, CurrentUSD2,147,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

2,108,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

2,177,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

2,136,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

2,098,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

2,167,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

2,126,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

2,087,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

2,157,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

2,100,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

2,087,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

2,287,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Accounts Payable, CurrentUSD4,656,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

8,438,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

4,179,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

20,025,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

5,765,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

3,335,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

11,981,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

4,297,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

4,856,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

6,417,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

3,794,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

2,678,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD5,288,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

6,791,000
Source

10-Q · 2024-11-13 · 0000950170-24-125943

As of 2024-09-30

4,050,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

5,680,000
Source

10-Q · 2025-08-14 · 0000950170-25-108427

As of 2025-06-30

7,139,000
Source

10-Q · 2024-08-12 · 0000950170-24-095057

As of 2024-06-30

4,472,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

6,054,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

7,471,000
Source

10-Q · 2024-05-09 · 0000950170-24-056247

As of 2024-03-31

4,884,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

6,437,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

7,786,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

9,000,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Additional Financial Items
Cash, Cash Equivalents, and Short-term InvestmentsUSD——234,200,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

——227,600,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

106,900,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

——128,500,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

——
Short-term InvestmentsUSD——————70,918,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

——86,504,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

——

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-20,196,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-32,656,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-99,961,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-98,333,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-66,394,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-59,277,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization———————
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

—
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

—
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

—
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

—
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——————2,755,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

3,697,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

12,132,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

12,474,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

3,043,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,781,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————-1,596,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

5,143,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-1,561,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

2,378,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-180,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-426,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-21,144,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-21,716,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-98,561,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-81,151,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-59,496,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-54,560,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————27,460,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

15,600,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-90,252,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-94,077,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-165,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-901,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————35,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

—397,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

481,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

115,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

672,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————2,452,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

11,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

216,795,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

88,776,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

103,791,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

189,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————8,768,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-6,105,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

27,982,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-86,452,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

44,130,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-55,272,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——44,244,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2025-09-30

160,272,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

As of 2024-09-30

96,082,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

38,728,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2025-06-30

75,016,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

32,161,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2025-03-31

66,248,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

As of 2025-12-31

38,266,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

124,718,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2023-12-31

80,588,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD————————104,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

127,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

176,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

77,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Income Taxes Paid, NetUSD————————551,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

———
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——2,651,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

3,790,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

5,690,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

3,071,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

2,755,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

3,697,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

12,132,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

12,474,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

3,043,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,781,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD————234,200,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

As of 2026-06-30

—227,600,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

As of 2026-03-31

106,900,000
Source

10-Q · 2025-05-12 · 0000950170-25-068536

As of 2025-03-31

—128,500,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

As of 2024-12-31

——
General and Administrative ExpenseUSD——5,953,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

8,120,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

8,993,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

15,967,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

6,630,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

16,634,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

45,460,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

31,675,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

15,383,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

12,001,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

———
InterestExpenseNonoperatingUSD——22,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

35,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

14,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

25,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

17,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

28,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

95,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

137,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

——
Investment Income, InterestUSD——1,456,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

2,092,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

2,194,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

1,268,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

2,113,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

1,193,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

6,130,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

7,556,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

2,867,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,325,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-20,283,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

-29,489,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

-25,867,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

-26,103,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-20,196,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-32,656,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-99,961,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-98,333,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-66,394,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-59,277,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——1,365,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

2,054,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

2,153,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

4,585,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

2,137,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

1,149,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

9,296,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

7,433,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

2,119,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,232,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Operating ExpensesUSD——21,648,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

31,543,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

28,020,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

30,688,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

22,333,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

33,805,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

109,257,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

105,766,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

68,513,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

61,163,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——667,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

653,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

665,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

663,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

668,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

663,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

2,650,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

2,606,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

2,502,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,795,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——-9,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

-3,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

-6,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

-14,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-1,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-4,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-18,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-9,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-13,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-2,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Payments to Acquire InvestmentsUSD————————195,382,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

93,596,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

——
Proceeds from Issuance of Common StockUSD——————143,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

170,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

270,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

———
Proceeds from Stock Options ExercisedUSD——————9,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

—59,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

491,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

51,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

332,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Unrealized Gain (Loss) on InvestmentsUSD——102,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

—-156,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

41,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-330,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

49,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

291,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-103,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

——

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD———————————654,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——-21,648,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

-31,543,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

-28,020,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

-30,688,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-22,333,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-33,805,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-109,257,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-105,766,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-68,513,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-60,509,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——-9,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

-3,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

-6,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

-14,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-1,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-4,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-18,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-9,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-13,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-2,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——-20,283,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

-29,489,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

-25,867,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

-26,103,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-20,196,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-32,656,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-99,670,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-98,333,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-66,394,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-59,277,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD——-20,283,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

-29,489,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

-25,867,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

-26,103,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-20,196,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-32,656,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-99,961,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-98,333,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-66,394,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-59,277,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.33
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

-0.89
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

-0.3
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

-0.6
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-0.25
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-0.99
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-1.86
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-3.09
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-12.4
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-36.36
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.33
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

-0.89
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

-0.3
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

-0.6
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

-0.25
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

-0.99
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

-1.86
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

-3.09
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

-12.4
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

-36.36
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——60,980,867
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

33,063,153
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

85,626,751
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

43,573,628
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

81,183,812
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

33,113,991
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

53,645,323
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

31,787,491
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

5,354,368
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,630,348
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——60,980,867
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

33,063,153
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

85,626,751
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

43,573,628
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

81,183,812
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

33,113,991
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

53,645,323
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

31,787,491
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

5,354,368
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,630,348
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Interest Expense (non-operating)USD——22,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

35,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

14,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

25,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

17,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

28,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

95,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

137,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

——
Additional Financial Items
Depreciation, Depletion and Amortization, NonproductionUSD——————73,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

60,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

268,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

304,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

271,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

120,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——5,953,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

8,120,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

8,993,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

15,967,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

6,630,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

16,634,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

45,460,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

31,675,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

15,383,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

12,001,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-99,670,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

———
Interest ExpenseUSD——————————205,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

91,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——1,456,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

2,092,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

2,194,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

1,268,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

2,113,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

1,193,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

6,130,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

7,556,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

2,867,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,325,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——1,365,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

2,054,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

2,153,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

4,585,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

2,137,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

1,149,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

9,296,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

7,433,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

2,119,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,232,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Operating ExpensesUSD——21,648,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

31,543,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

28,020,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

30,688,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

22,333,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

33,805,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

109,257,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

105,766,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

68,513,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

61,163,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD——667,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

653,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

665,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

663,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

668,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

663,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

2,650,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

2,606,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

2,502,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

1,795,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——15,695,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2025-07-01 to 2025-09-30

23,423,000
Source

10-Q · 2025-11-05 · 0001193125-25-265757

2024-07-01 to 2024-09-30

19,027,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2026-04-01 to 2026-06-30

14,721,000
Source

10-Q · 2026-08-12 · 0001193125-26-345724

2025-04-01 to 2025-06-30

15,703,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2026-01-01 to 2026-03-31

17,171,000
Source

10-Q · 2026-05-11 · 0001193125-26-215678

2025-01-01 to 2025-03-31

63,797,000
Source

10-K · 2026-03-30 · 0001193125-26-132085

2025-01-01 to 2025-12-31

74,091,000
Source

10-K · 2025-03-24 · 0000950170-25-043486

2024-01-01 to 2024-12-31

53,130,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2023-01-01 to 2023-12-31

49,162,000
Source

10-K · 2024-03-11 · 0000950170-24-028941

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-299689

S-3 · 2026-10-29 · 0001193125-26-437001

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

lxeo-ex99_1.htm · 8-K · 2026-11-16

Exhibit 99.1 Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Reports Third Quarter 2026 Financial Results Participants in high-dose cohorts achieved 80% mean reduction in non-sustained ventricular tachycardia and 44% mean reduction in premature ventricular contractions at latest assessment LX2020 generally well tolerated across 10 participants with no clinically significant complement activation U.S. Fo…

8-K · 2026-11-16 · 0001193125-26-462015

Read attachment ↗
lxeo-ex99_2.htm · 8-K · 2026-11-16

Interim Clinical Data from the Phase 1/2 HEROIC-PKP2 Trial of LX2020 in PKP2 Arrhythmogenic Cardiomyopathy November 16, 2026 Exhibit 99.2 1 Certain statements in this presentation may constitute “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, Lexeo’s expectations and plans regarding its current product candidates and programs, the anticipated benefits of its current product candidates, and the timing and likelihood of potential regu…

8-K · 2026-11-16 · 0001193125-26-462015

Read attachment ↗
d238747dex43.htm · S-3 · 2026-10-29

Exhibit 4.3 LEXEO THERAPEUTICS, INC. INDENTURE Dated as of, 20 [__________] Trustee -1- TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 4 Section 1.3 Incorporation by Reference of Trust Indenture Act 4 Section 1.4 Ru…

S-3 · 2026-10-29 · 0001193125-26-437001

Read attachment ↗
lxeo-ex99_1.htm · 8-K · 2026-09-22

Exhibit 99.1 Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia Acquisition of Mantle Therapeutics will add multiple new modalities designed to increase or replace frataxin in the brain Collaborations launched to evaluate gene therapy sequential dosing following treatment with LX2006 and explore cerebellar targeting to optimize outcomes in FA associated neurological disease SUNR…

8-K · 2026-09-22 · 0001193125-26-397221

Read attachment ↗
lxeo-ex99_2.htm · 8-K · 2026-09-22

Business Update September 22, 2026 Exhibit 99.2 1 This presentation contains “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, Lexeo’s expectations and plans regarding its current product candidates and programs, the anticipated benefits of its current product candidates, the timing for receipt and announcement of data from its clinical trials, the timing and likelihood of potential regulatory developments, trial design changes and ap…

8-K · 2026-09-22 · 0001193125-26-397221

Read attachment ↗
lxeo-ex99_1.htm · 8-K · 2026-08-12

EX-99.1 2 lxeo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights Finalized SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 in support of accelerated approval pathway; topline data expected in second half of 2027 Initiated SUNRISE-FA 2 with first patient enrolled into pivotal study in June; site activation efforts ongoing CLARITY-FA enrollment continues to advance, supporting identificati…

8-K · 2026-08-12 · 0001193125-26-345722

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.